YCM
SAGE

Yakira Capital Management’s Sage Therapeutics SAGE Stock Holding History

Yakira Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-182,634
Closed -$1.67M – 223
2025
Q2 		$1.67M Buy
+182,634
New +$1.34M 0.57% 51

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Yakira Capital Management's SAGE Position: Q3 2025 in Review

Yakira Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 182,634 shares — an estimated $1.67M sold.

Yakira Capital Management first reported a position in SAGE in Q2 2025 and held it in 1 quarter. The position peaked at $1.67M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Yakira Capital Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Yakira Capital Management sold 182,634 Sage Therapeutics shares in Q3 2025, an estimated $1.67M.
  • Yakira Capital Management first reported a position in Sage Therapeutics in Q2 2025 and held it in 1 quarter.
  • Yakira Capital Management's Sage Therapeutics position peaked at $1.67M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Yakira Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.